DALLAS--(BUSINESS WIRE)--Oct. 28, 2005--ULURU INC. ("ULURU"), is an emerging pharmaceutical company focused on the development of a portfolio of innovative topical delivery technologies to provide patients and consumers with an improved clinical outcome through controlled delivery. ULURU was formed to acquire the topical assets of Access Pharmaceuticals, Inc. and subsequently merge with Oxford Ventures, Inc. (OTC bulletin board: OXFV). The companies have now entered a definitive merger agreement.
